Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 64630-63-3 | MDL No. : | MFCD28364662 |
Formula : | C10H14O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DPTGFYXXFXSRIR-UHFFFAOYSA-N |
M.W : | 182.22 | Pubchem ID : | 12860205 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.7 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.85 |
TPSA : | 38.83 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.3 cm/s |
Log Po/w (iLOGP) : | 2.46 |
Log Po/w (XLOGP3) : | 1.57 |
Log Po/w (WLOGP) : | 1.28 |
Log Po/w (MLOGP) : | 1.2 |
Log Po/w (SILICOS-IT) : | 1.99 |
Consensus Log Po/w : | 1.7 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.69 |
Solubility : | 3.68 mg/ml ; 0.0202 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.0 |
Solubility : | 1.84 mg/ml ; 0.0101 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.13 |
Solubility : | 13.5 mg/ml ; 0.0743 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.27 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 3232-07-3 ]
Bicyclo[2.2.1]hept-5-en-2-yl methacrylate
Similarity: 0.67
[ 3130-19-6 ]
Bis(7-oxabicyclo[4.1.0]heptan-3-ylmethyl) adipate
Similarity: 0.77
[ 41088-52-2 ]
Methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate
Similarity: 0.72
[ 77341-67-4 ]
4-(((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)-4-oxobutanoic acid
Similarity: 0.72
[ 3618-04-0 ]
trans-Ethyl 4-hydroxycyclohexanecarboxylate
Similarity: 0.72
[ 3130-19-6 ]
Bis(7-oxabicyclo[4.1.0]heptan-3-ylmethyl) adipate
Similarity: 0.77
[ 41088-52-2 ]
Methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate
Similarity: 0.72
[ 63095-51-2 ]
(R)-4-Propyldihydrofuran-2(3H)-one
Similarity: 0.64
[ 15356-74-8 ]
4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one
Similarity: 0.64
[ 3130-19-6 ]
Bis(7-oxabicyclo[4.1.0]heptan-3-ylmethyl) adipate
Similarity: 0.77
[ 41088-52-2 ]
Methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate
Similarity: 0.72
[ 171361-65-2 ]
Ethyl 1-oxaspiro[2.5]octane-6-carboxylate
Similarity: 0.71
[ 60456-26-0 ]
(R)-Oxiran-2-ylmethyl butyrate
Similarity: 0.55
[ 3130-19-6 ]
Bis(7-oxabicyclo[4.1.0]heptan-3-ylmethyl) adipate
Similarity: 0.77
[ 41088-52-2 ]
Methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate
Similarity: 0.72
[ 171361-65-2 ]
Ethyl 1-oxaspiro[2.5]octane-6-carboxylate
Similarity: 0.71
[ 17092-92-1 ]
(R)-4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one
Similarity: 0.64